Therapies

Exploring therapies for health, prevention and longevity

Health science continues to develop. Vivarta is exploring established and emerging therapies for their potential roles across health, recovery and healthy ageing, looking beyond the headlines at the evidence and its limits, safety, clinical appropriateness and governance, and how each might responsibly fit into our wider approach.

Coming soon to Vivarta Health. New services and therapies are being considered for introduction. We look carefully at the evidence, safety and governance before making anything available, and we have not set launch dates. These therapies cannot be booked yet.

Red light therapyHyperbaric oxygenCompression therapyCryotherapyOzone therapy

Red light therapy (photobiomodulation)

Coming soon to Vivarta Health

What is it?

Photobiomodulation uses low-level red or near-infrared light, from LEDs or low-power lasers, applied to the skin. It does not heat or cut tissue. The idea is that particular wavelengths are absorbed by cells and can influence how they work.

What does the evidence tell us?

The strongest evidence is in specific clinical uses. International cancer-care guidelines (MASCC/ISOO) recommend photobiomodulation to help prevent oral mucositis, the painful mouth sores that can follow some cancer treatments. Trials in some painful musculoskeletal conditions, such as neck pain, have also reported benefits.

Where is research still developing?

Research into skin health, tissue recovery and inflammation is active, but results vary with the device, wavelength, dose and number of sessions, and many studies are small. Studies of brain health and cognitive decline, including Alzheimer's disease, are at an early stage: it is not an established treatment for any form of dementia.

Why is Vivarta exploring it?

It is a low-risk, non-invasive approach with a growing research base. We want to understand which uses are supported, which devices and protocols match that research, and how it could sit alongside a proper assessment.

Sources

Hyperbaric oxygen therapy

Coming soon to Vivarta Health

What is it?

Hyperbaric oxygen therapy (HBOT) means breathing high concentrations of oxygen while inside a chamber pressurised above normal air pressure. This raises the amount of oxygen carried in the blood.

What does the evidence tell us?

HBOT is an established treatment for a small number of medical conditions, such as decompression illness in divers and some cases of carbon monoxide poisoning, and is used for selected problems such as certain non-healing wounds and radiation injuries. In the NHS it is provided in specialist centres for these indications.

Where is research still developing?

Research into recovery, general health and healthy ageing is newer and mostly small or early-stage. Evidence from recognised medical uses cannot be transferred to broad claims about longevity or wellbeing. HBOT also carries risks, including ear and sinus pressure injury, and is not suitable for everyone.

Why is Vivarta exploring it?

Interest in HBOT is growing well beyond its established uses. We want to separate what is known from what is being claimed, and understand what a safe, clinically governed service would require.

Sources

Compression therapy

Coming soon to Vivarta Health

What is it?

Compression therapy applies controlled pressure to the limbs. Intermittent pneumatic compression uses inflatable sleeves that fill and empty in cycles to squeeze and release the legs or arms, encouraging blood and fluid to move.

What does the evidence tell us?

Compression has established clinical uses. In hospitals, intermittent pneumatic compression is one of the methods NICE recommends to reduce the risk of blood clots (venous thromboembolism) in some patients, and compression is a standard part of managing conditions such as lymphoedema.

Where is research still developing?

Consumer and sports recovery systems are different from these clinical uses. Research on recovery and general wellbeing is limited and mixed, and evidence from hospital clot prevention does not show a general wellness benefit. Compression is not suitable for some people, including those with certain circulation problems, a suspected or recent blood clot, heart failure or skin conditions on the treated area.

Why is Vivarta exploring it?

Compression is widely used for recovery. We want to understand where it may genuinely help, which people should not use it, and how it could be offered with appropriate screening.

Sources

Cryotherapy

Coming soon to Vivarta Health

What is it?

Cryotherapy means controlled exposure to cold. Whole-body cryotherapy, which we are exploring, involves a short, supervised stay of a few minutes in a chamber of very cold air.

What does the evidence tell us?

A Cochrane review found too little good-quality evidence to say whether whole-body cryotherapy reduces muscle soreness or improves recovery after exercise. Cold exposure does change circulation and some inflammatory markers in the short term.

Where is research still developing?

Claims about weight loss, metabolic change, immune enhancement and longevity are not supported by good evidence. Screening and safety protocols matter: whole-body cryotherapy is not suitable for people with certain heart and circulation conditions, uncontrolled high blood pressure, Raynaud's phenomenon, cold sensitivity or pregnancy.

Why is Vivarta exploring it?

Many people use cold exposure for recovery and wellbeing. We want to set realistic expectations and make sure any service would include proper screening and supervision.

Sources

Ozone therapy

Coming soon to Vivarta Health

What is it?

Medical ozone therapy uses a mixture of medical-grade oxygen and ozone. Several methods of giving it have been investigated, including applying it to the skin or a wound, injecting it into joints, and treating a small amount of the person's own blood before returning it.

What does the evidence tell us?

Research exists across several clinical areas, but the quality and certainty of the evidence vary widely, and many studies are small or at risk of bias. Ozone is not an established treatment for general wellness, ageing or disease prevention. Inhaled ozone is harmful to the lungs, and some methods of administration carry significant risks.

Where is research still developing?

For several proposed uses, reviews have found the evidence insufficient to draw firm conclusions. For example, a Cochrane review found no reliable evidence that ozone treatment stops or reverses tooth decay.

Why is Vivarta exploring it?

At Vivarta, we are reviewing the evidence, safety requirements and clinical governance surrounding ozone therapy before deciding how it might form part of our services. We will only introduce it where there is a responsible and clinically appropriate pathway for doing so.

Sources

These descriptions explain what each therapy involves and what the evidence shows. They are not claims that a therapy treats, prevents or cures any condition. Our current services are health assessments, blood tests and vitamins, supplements and IV therapy.

Questions

Want to know more?

Ask us about any of these therapies. We will tell you honestly what the evidence shows and where we are in assessing it.

Speak to our team